To investigate whether MSC could regulate CRC growth and enhance the efficacy of αPD1, the following groups were designed: control group, αPD1-treated group, MSC × cIg-treated, and αPD1 × MSC mixed treatment. Here, FN1 is linked to colorectal carcinoma.